Why the study?
Does the Intermedics Intertach 262-12 pacemaker improve arrhythmia control in patients with tachycardia who failed drug treatment?
Does the Intermedics Intertach 262-12 pacemaker improve arrhythmia control in patients with tachycardia who failed drug treatment?
The Intermedics Intertach 262-12 pacemaker provided complete arrhythmia control in a small series of patients refractory to drug therapy.
Answers are grounded in this paper and cite their sources.
Should not yet change practice; leaves open the role of this pacemaker in refractory tachycardia pending prospective data.
Current generation antitachycardia pacemakers suffer from limitations concerning detection and distinction of pathological tachycardia and also from the termination modes available. To overcome many of these limitations, a new device (Intermedics Intertach 262-12) has been developed, and has now been implanted in nine patients, all of whom had failed drug treatment. Since implantation, all patients have complete control of their arrhythmias, and only one now requires drug therapy.
No takes yet. Share an insight, caveat, or question.
Nathan et al. (1986) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: